Every Monday our authors provide a round-up of some of the most recently published peer reviewed articles from the field. We don’t cover everything, or even what’s most important – just a few papers that have interested… Read More »Chris Sampson’s journal round-up for 14th March 2016
In a previous post I asked whether the study by Claxton et al can or should inform the cost-effectiveness threshold used by NICE. The authors argued that, “it is the expected health effects … of… Read More »Identifying the effect of expenditure on health outcomes: another small comment on Claxton et al
The cost-effectiveness threshold utilised by health technology assessment agencies, such as NICE in the United Kingdom, below which new medical technologies and interventions are considered cost-effective, is frequently discussed. NICE currently use a threshold of… Read More »Do we really need to change the cost-effectiveness threshold?